Department of Hematology, Wuhan Fourth Hospital, Puai Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Bioengineered. 2022 Mar;13(3):6409-6419. doi: 10.1080/21655979.2022.2044249.
Acute lymphocytic leukemia (ALL) is the most common malignant tumor in children with T-cell ALL (T-ALL), accounting for approximately 15% of all cases. Long noncoding RNAs (lncRNAs) are involved in the pathogenesis and progression of T-ALL. The present study aimed to explore the role and mechanism of action of lncRNA EBLN3P in T-ALL. We used quantitative reverse transcription-PCR (qRT-PCR) to determine the expression of lncRNA endogenous bornavirus-like nucleoprotein (EBLN3P), microRNA (miR)-655-3p, and the transcription level of matrix metalloproteinase-9 (MMP-9), and Western blot assay to quantify the protein expression level of cleaved-caspase3, caspase3, proliferating cell nuclear antigen (PCNA), and MMP-9. The potential binding sites between lncRNA EBLN3P and miR-655-3p were predicted using StarBase, and the interaction was further verified by dual-luciferase reporter assay and RNA pull-down assay. The proliferation ability of Jurkat cells was detected using MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay, and their invasion and migration ability using transwell assay. Cell apoptosis was determined using flow cytometry (FCM) assay. The expression of lncRNA EBLN3P was upregulated while that of miR-655-3p was downregulated in human T-ALL cell lines and lncRNA EBLN3P negatively regulated miR-655-3p. LncRNA EBLN3P knockdown significantly inhibited proliferation, invasion, and migration of Jurkat cells and induced their apoptosis. Downregulating miR-655-3p reversed the effects of lncRNA EBLN3P knockdown on Jurkat cells. In conclusion, we confirmed for the first time that lncRNA EBLN3P is dysregulated in T-ALL cell lines, and lncRNA EBLN3P knockdown inhibited the malignant biological behaviors of T-ALL cells by up-regulating miR-655-3p.
急性淋巴细胞白血病(ALL)是儿童中最常见的恶性肿瘤,其中 T 细胞 ALL(T-ALL)约占所有病例的 15%。长链非编码 RNA(lncRNA)参与 T-ALL 的发病机制和进展。本研究旨在探讨 lncRNA EBLN3P 在 T-ALL 中的作用和作用机制。我们使用定量逆转录-PCR(qRT-PCR)来确定 lncRNA 内源性 bornavirus 样核蛋白(EBLN3P)、微小 RNA(miR)-655-3p 的表达和基质金属蛋白酶-9(MMP-9)的转录水平,并用 Western blot 测定法来定量测定 cleaved-caspase3、caspase3、增殖细胞核抗原(PCNA)和 MMP-9 的蛋白表达水平。使用 StarBase 预测 lncRNA EBLN3P 和 miR-655-3p 之间的潜在结合位点,并通过双荧光素酶报告基因测定和 RNA 下拉测定进一步验证相互作用。使用 MTT(3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四唑溴盐)测定法检测 Jurkat 细胞的增殖能力,用 Transwell 测定法检测其侵袭和迁移能力。用流式细胞术(FCM)测定细胞凋亡。在人 T-ALL 细胞系中上调 lncRNA EBLN3P 的表达并下调 miR-655-3p 的表达,lncRNA EBLN3P 负调控 miR-655-3p。lncRNA EBLN3P 敲低显著抑制 Jurkat 细胞的增殖、侵袭和迁移,并诱导其凋亡。下调 miR-655-3p 逆转了 lncRNA EBLN3P 敲低对 Jurkat 细胞的影响。综上所述,我们首次证实 lncRNA EBLN3P 在 T-ALL 细胞系中失调,lncRNA EBLN3P 敲低通过上调 miR-655-3p 抑制 T-ALL 细胞的恶性生物学行为。